-
Product Insights
NewMajor Depressive Disorder – Drugs In Development, 2024
Empower your strategies with our Major Depressive Disorder – Drugs In Development, 2024 report and make more profitable business decisions. Major Depressive Disorder (MDD) is a common and severe mental health condition characterized by persistent feelings of sadness, hopelessness, and a lack of interest or pleasure in daily activities. Symptoms may include changes in appetite and sleep patterns, fatigue, difficulty concentrating, feelings of worthlessness, and thoughts of death or suicide. Diagnosis is based on the duration and intensity of these symptoms....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SPYK-04 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SPYK-04 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SPYK-04 in Non-Small Cell Lung Cancer Drug Details:SPYK-04 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lysergic Acid Diethylamide in Attention Deficit Hyperactivity Disorder (ADHD)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Lysergic Acid Diethylamide in Attention Deficit Hyperactivity Disorder (ADHD) Drug Details: Lysergic acid diethylamide...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Buspirone Hydrochloride + Testosterone) in Female Hypoactive Sexual Desire Disorder
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Buspirone Hydrochloride + Testosterone) in Female Hypoactive Sexual Desire Disorder Drug Details: Buspirone hydrochloride...
-
Product Insights
Clinical Decision Support Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clinical Decision Support Systems Pipeline Market Report Overview The Clinical Decision Support Systems (CDSS) are software tools that assist healthcare professionals with decision-making. The software consolidates a medical knowledge base with patient information to produce case-specific advice. The Clinical Decision Support Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the...
-
Company Profile
Mind Medicine MindMed Inc – Company Profile
Mind Medicine MindMed Inc (MindMed) is a pharmaceutical drug development and clinical research company. The company develops medicinal products to treat brain health disorders, psychiatry, pain and substance use disorders, and related therapeutic areas. Its product offerings include psychedelic and empathogen drugs. The company offers research and development supports such as non-clinical, pre-clinical, human clinical trials and investigator-initiated trials. It also develops drugs support clinical data opportunity in autism spectrum disorders (ASD), address a critical gap in opioid use disorder...
Add to Basket -
Product Insights
Net Present Value Model: Zolunicant Hydrochloride
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Zolunicant Hydrochloride Drug Details 18-Methoxycoronaridine (18-MC)...
-
Product Insights
Net Present Value Model: MM-120
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model MM-120 Drug Details Lysergic acid diethylamide...
-
Product Insights
Net Present Value Model: MM-290
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model MM-290 Drug Details Lysergic acid diethylamide...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – lysergic acid diethylamide
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry lysergic acid diethylamide Drug Details Lysergic acid diethylamide is under development for the treatment...